• Ticker:- PPH;false;MVPPH;
  • Ticker Group:- ETFEQ_IND;false;;
  • Making News

    ETF Daily News: How to Profit from the Rise of Macau


    3/7/14: ETF Daily News discusses the performance of gaming market Macau and mentions BJK. “Macau’s rise to prominence has been swift.”
    View article » 



    Benzinga: Interesting Similarities Among 2013's Top-Performing ETFs


    6/18/13: Todd Shriber evaluates the year’s notable ETFs and mentions BBH. He remarks that “biotech ETFs big and small have been stellar performers this year."
    View article » 



    Zacks Equity Research: Semiconductor ETFs for 2013?


    2/07/13: Zacks Equity Research reports that the semiconductor industry is "set to rebound in 2013 with the recovery projected to pick up speed in the latter part of the year" and advises investors to consider SMH as a vehicle for accessing the space.
    View article » 



  • How to Purchase

Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

Pharmaceutical ETF PPH

  • Full Name: Market Vectors®
    Pharmaceutical ETF (PPH)

    Management Style: Replication

    Underlying Index: Market Vectors US Listed Pharmaceutical 25 Index (MVPPHTR)

    Index Description: MVPPHTR is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded pharmaceutical companies.

  •  
     

    • Fund Ticker

      PPH
    • Exchange

      NYSE Arca
    • Index Total Return Ticker

      MVPPHTR
    • Index Provider

      Market Vectors Index Solutions
    • Total Net Assets

      $322.4M
    • Shares Outstanding

      5,438,138
    • Number of Holdings

      26
    • Commencement Date

      12/20/2011
  •  
    as of 04/22/14

  • Fundamentals
    as of 03/31/14

    • Weighted Average Market Cap

      $117.4B
    • Price/Earnings Ratio
      (LTM: Last 12 Months)*

      24.38
    • Price/Book Ratio
      (LTM: Last 12 Months)*

      3.73
    *A weighted harmonic average is used to calculate this metric. Price/Book Ratio is the price of a security divided by the book value per share of the security. Price/Earnings Ratio is the price of a security divided by the last twelve months earnings per share of the security.
  • Market Capitalization (%)
    as of 03/31/14

    • Capitalization

      % of Net
      Assets ($)
    • Large (>$5.0B)

      99.5%
    • Mid ($1.0 - $5.0B)

      0.4%
    • Small (<$1.0B)

      0.0%
    This breakdown represents what percentage of the ETF's assets represent large/mid/small-sized companies. The market capitalization of an individual, publicly traded company is calculated by multiplying the company's stock price by the total number of its shares outstanding.
  • 3-YR Risk Measures
    as of 03/31/14

    • Beta vs. S&P 500 Index

    • Correlation vs. S&P 500 Index

    • Volatility (Standard Deviation)

    • Sharpe Ratio

    Source: Van Eck Global, FactSet.

    Beta is a measure of sensitivity to market movements. Correlation measures the extent of linear association between the ETF performance and the index performance. Volatility is the annualized standard deviation of the ETF's monthly returns. Sharpe ratio measures risk-adjusted return, and represents the ETF's return less the risk free rate divided by the standard deviation.

  • Country Weightings (%)
    as of 03/31/14

    • Country

      % of Net Assets
    • U.S.

      59.1
    • UNITED KINGDOM

      9.3
    • SWITZERLAND

      9.0
    • FRANCE

      5.2
    • DENMARK

      5.1
    • ISRAEL

      4.8
    • CANADA

      4.1
    • IRELAND

      3.2
    • Other

      0.1
    • Total

      99.9
  • Portfolio Composition (%)
    as of 04/22/14

    • % of Net Assets

    • Stocks

      100.10
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      -0.10
    • Total

      100.00
  • Sector Weightings (%)
    as of 03/31/14

    • Sector

      % of Net Assets
    • Health Care

      99.9
    • Other

      0.1
    • Total

      100.0
  • Currency Exposure (%)
    as of 03/31/14

    • U.S. Dollar

      99.86
    • Other

      0.14
    • Total

      100.00